Colombo, January 22 Sri Lanka’s Minister of State for Drug Production, Supply and Supervision Jaya Sumana announced on the 22nd that Sri Lanka’s National Drug Administration officially approved the emergency use of the coronavirus vaccine developed by Oxford University and AstraZeneca Pharmaceutical Company on the same day.
Jayasumana told the Sri Lankan media on the same day that the above vaccine is the first coronavirus vaccine approved by Sri Lanka for emergency use in the country, and several other vaccines are still awaiting approval by Sri Lanka’s National Drug Administration.
According to the media quoted Fernando Plai, Sri Lanka’s Minister of State for basic health services, epidemics and the prevention and control of the novel coronavirus, Sri Lanka plans to reach at least 50% of the country’s population, and 20% of the vaccines will be used by participating in the “COVID-19 vaccine”.
The plan” is obtained, and the government will buy a vaccine for the coronavirus for another 30% of the population.
As of the 22nd, Sri Lanka has more than 56,000 confirmed cases of COVID-19 and 276 deaths.